Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
2016 | 1 |
2018 | 1 |
2024 | 0 |
PubMed for id: 277419
3 results
Results by year
Filters applied: . Clear all
Page 1
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON).
Breast Cancer. 2018 May;25(3):356-364. doi: 10.1007/s12282-018-0838-8. Epub 2018 Feb 15.
Breast Cancer. 2018.
PMID: 29450827
Clinical Trial.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Robertson JFR, Bondarenko IM, Trishkina E, Dvorkin M, Panasci L, Manikhas A, Shparyk Y, Cardona-Huerta S, Cheung KL, Philco-Salas MJ, Ruiz-Borrego M, Shao Z, Noguchi S, Rowbottom J, Stuart M, Grinsted LM, Fazal M, Ellis MJ.
Robertson JFR, et al.
Lancet. 2016 Dec 17;388(10063):2997-3005. doi: 10.1016/S0140-6736(16)32389-3. Epub 2016 Nov 29.
Lancet. 2016.
PMID: 27908454
Clinical Trial.
Item in Clipboard
Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
Nishida T, Nagasue N, Izumi S, Sakihama H, Yakushiji M.
Nishida T, et al.
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Feb;42(2):193-8.
Nihon Sanka Fujinka Gakkai Zasshi. 1990.
PMID: 1690254
Item in Clipboard
Cite
Cite